SE0203825D0 - Novel fused heterocycles and uses thereof - Google Patents
Novel fused heterocycles and uses thereofInfo
- Publication number
- SE0203825D0 SE0203825D0 SE0203825A SE0203825A SE0203825D0 SE 0203825 D0 SE0203825 D0 SE 0203825D0 SE 0203825 A SE0203825 A SE 0203825A SE 0203825 A SE0203825 A SE 0203825A SE 0203825 D0 SE0203825 D0 SE 0203825D0
- Authority
- SE
- Sweden
- Prior art keywords
- fused heterocycles
- novel fused
- novel compounds
- novel
- heterocycles
- Prior art date
Links
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000010586 diagram Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0203825A SE0203825D0 (sv) | 2002-12-20 | 2002-12-20 | Novel fused heterocycles and uses thereof |
US10/539,936 US20070004761A1 (en) | 2002-12-20 | 2003-12-19 | Pyrazolo [3,4-d] pyrimidine derivatives and their use in the treatment of h.pylori infection |
ES03781250T ES2278211T3 (es) | 2002-12-20 | 2003-12-19 | Derivados de pirazolo 3,4-d pirimidina y su uso en el tratamiento de infeccion por h. pylori. |
AU2003288869A AU2003288869A1 (en) | 2002-12-20 | 2003-12-19 | PYRAZOLO (3,4-d) PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION |
AT03781250T ATE349448T1 (de) | 2002-12-20 | 2003-12-19 | Pyrazol-3,4-d-pyrimidinderivate und ihre verwendung bei der behandlung von h.pylori- infektionen |
PCT/SE2003/002033 WO2004056831A1 (en) | 2002-12-20 | 2003-12-19 | PYRAZOLO [3,4-d] PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION |
JP2004562221A JP2006512366A (ja) | 2002-12-20 | 2003-12-19 | ピラゾロ[3,4−d]ピリミジン誘導体及び処置におけるその使用 |
DE60310767T DE60310767T2 (de) | 2002-12-20 | 2003-12-19 | PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN |
EP03781250A EP1585748B1 (en) | 2002-12-20 | 2003-12-19 | PYRAZOLO 3,4-d PYRIMIDINE DERIVATIVES AND THEIR USE I N THE TREATMENT OF H.PYLORI INFECTION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0203825A SE0203825D0 (sv) | 2002-12-20 | 2002-12-20 | Novel fused heterocycles and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0203825D0 true SE0203825D0 (sv) | 2002-12-20 |
Family
ID=20289974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0203825A SE0203825D0 (sv) | 2002-12-20 | 2002-12-20 | Novel fused heterocycles and uses thereof |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070004761A1 (xx) |
EP (1) | EP1585748B1 (xx) |
JP (1) | JP2006512366A (xx) |
AT (1) | ATE349448T1 (xx) |
AU (1) | AU2003288869A1 (xx) |
DE (1) | DE60310767T2 (xx) |
ES (1) | ES2278211T3 (xx) |
SE (1) | SE0203825D0 (xx) |
WO (1) | WO2004056831A1 (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL160307A0 (en) | 2001-08-31 | 2004-07-25 | Univ Rockefeller | Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
KR20090042227A (ko) | 2006-06-06 | 2009-04-29 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
ES2411604T3 (es) | 2006-11-13 | 2013-07-05 | Intra-Cellular Therapies, Inc. | Compuestos orgánicos |
CN101969774A (zh) | 2007-12-06 | 2011-02-09 | 细胞内治疗公司 | 有机化合物 |
JP5216912B2 (ja) | 2008-04-29 | 2013-06-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ccr1受容体拮抗薬としてのインダゾール化合物 |
JP5411927B2 (ja) * | 2008-05-06 | 2014-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ccr1アンタゴニストとしてのピラゾール化合物 |
KR20110060904A (ko) | 2008-09-26 | 2011-06-08 | 베링거 인겔하임 인터내셔날 게엠베하 | Ccr1 수용체 길항제로서의 아자인다졸 화합물 |
PE20120120A1 (es) | 2008-12-06 | 2012-03-03 | Intra Cellular Therapies Inc | DERIVADOS DE 2H-PIRAZOLO[3,4-d]PIRIMIDINA-4,6(5H,7H)-DIONA, COMO INHIBIDORES DE PDE1 |
WO2010065147A1 (en) | 2008-12-06 | 2010-06-10 | Intra-Cellular Therapies, Inc. | Organic compounds |
JP5710493B2 (ja) | 2008-12-06 | 2015-04-30 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 有機化合物 |
SG178279A1 (en) | 2009-08-05 | 2012-03-29 | Intra Cellular Therapies Inc | Novel regulatory proteins and inhibitors |
PE20121433A1 (es) | 2009-10-21 | 2012-11-10 | Boehringer Ingelheim Int | Compuestos de indazol y pirazolopiridina como antagonistas del receptor de ccr1 |
JP5542214B2 (ja) | 2009-10-27 | 2014-07-09 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ccr1受容体アンタゴニストとしての複素環化合物 |
MX2012006524A (es) * | 2009-12-08 | 2012-07-17 | Boehringer Ingelheim Int | Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol. |
WO2011137109A1 (en) | 2010-04-30 | 2011-11-03 | Boehringer Ingelheim International Gmbh | Azaindazole amide compounds as ccr1 receptor antagonists |
WO2011153135A1 (en) | 2010-05-31 | 2011-12-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
US9434730B2 (en) | 2010-05-31 | 2016-09-06 | Intra-Cellular Therapies, Inc. | PDE1 inhibitor compounds |
US8546442B2 (en) | 2010-12-23 | 2013-10-01 | Boehringer Ingelheim International Gmbh | Pyrazolopiperidine compounds as CCR1 receptor antagonists |
US9546175B2 (en) | 2014-08-07 | 2017-01-17 | Intra-Cellular Therapies, Inc. | Organic compounds |
WO2019233994A1 (en) | 2018-06-04 | 2019-12-12 | Exscientia Ltd | Pyrazolopyrimidine compounds as adenosine receptor antagonists |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3839839A1 (de) * | 1988-11-25 | 1990-05-31 | Henning Berlin Gmbh | Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen |
SE0102315D0 (sv) * | 2001-06-28 | 2001-06-28 | Astrazeneca Ab | Compounds |
-
2002
- 2002-12-20 SE SE0203825A patent/SE0203825D0/xx unknown
-
2003
- 2003-12-19 ES ES03781250T patent/ES2278211T3/es not_active Expired - Lifetime
- 2003-12-19 AU AU2003288869A patent/AU2003288869A1/en not_active Abandoned
- 2003-12-19 JP JP2004562221A patent/JP2006512366A/ja active Pending
- 2003-12-19 AT AT03781250T patent/ATE349448T1/de not_active IP Right Cessation
- 2003-12-19 EP EP03781250A patent/EP1585748B1/en not_active Expired - Lifetime
- 2003-12-19 US US10/539,936 patent/US20070004761A1/en not_active Abandoned
- 2003-12-19 DE DE60310767T patent/DE60310767T2/de not_active Expired - Fee Related
- 2003-12-19 WO PCT/SE2003/002033 patent/WO2004056831A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE60310767T2 (de) | 2007-10-11 |
WO2004056831A1 (en) | 2004-07-08 |
DE60310767D1 (de) | 2007-02-08 |
AU2003288869A1 (en) | 2004-07-14 |
ATE349448T1 (de) | 2007-01-15 |
EP1585748B1 (en) | 2006-12-27 |
JP2006512366A (ja) | 2006-04-13 |
US20070004761A1 (en) | 2007-01-04 |
EP1585748A1 (en) | 2005-10-19 |
ES2278211T3 (es) | 2007-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0203825D0 (sv) | Novel fused heterocycles and uses thereof | |
SE0102315D0 (sv) | Compounds | |
ATE423122T1 (de) | Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri) | |
MXPA05009885A (es) | Nuevas triazolonas fusionadas y los usos de las mismas. | |
DE60225040D1 (de) | Montelukast-granulatformulierung | |
BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
BR0116452A (pt) | Composto, composição farmacêutica, uso de um composto | |
CY1109422T1 (el) | Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου | |
EA201000643A1 (ru) | Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе | |
NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
DK1200418T3 (da) | Nematodicide trifluorbutener | |
NO20033181D0 (no) | Substituerte alkylaminderivater og fremgangsmater for anvendelse | |
DK1855677T3 (da) | 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser | |
ECSP055844A (es) | Nuevos compuestos triciclicos | |
MY141233A (en) | Enantiomers of selected fused heterocyclics and uses thereof | |
YU102503A (sh) | Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva | |
CY1105275T1 (el) | Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda | |
TW200621260A (en) | Selected fused heterocyclics and uses thereof | |
SG162614A1 (en) | Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors | |
MY141583A (en) | Novel fused heterocycles and uses thereof | |
ATE335739T1 (de) | Cak inhibitoren und deren verwendungen | |
DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
SE0004101D0 (sv) | New use | |
ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |